Search

Search results

12 results found

Joan Miller, MD, appointed to AUPO Board of Trustees

Joan W. Miller, MD, has been appointed to the Association of University Professors of Ophthalmology (AUPO) Board of Trustees. As Chair of Harvard Ophthalmology since 2003, Dr. Miller is committed driving innovation and quality in academic medicine, and strongly supports mentoring and developing...

Michael Gilmore, PhD, chairs $20 million antibiotic-resistance challenge

In March 2017, Michael Gilmore, PhD, Director of the Harvard Infectious Disease Institute, chaired a blue ribbon panel that reviewed the most promising applications for the Antimicrobial Resistance Diagnostic Challenge--a $20 million federal prize competition to develop innovative, rapid point-of...

Recent grants - March 2017

James Chodosh, MD, MPH, received a NIH R01 in the amount of $1.7M over four years for his project, "Immunopathogenesis of Adenovirus Keratitis." Tobias Elze, PhD, received a BrightFocus Award in the amount of $150,000 over two years for his project, "Computational Investigation of Glaucoma...

Jae-Hyun Jung, PhD, receives 2017 Alice J. Adler Fellowship

Jae-Hyun Jung, PhD, is the recipient of the 2017 Alice J. Adler Fellowship of the Schepens Eye Research Institute of Mass. Eye and Ear in the amount of $30,000 over one year for his project, “The best field expansion configuration for using multiplexing prism for homonymous hemianopia.” This award...

Researchers identify mechanism of retina damage following chemical eye burns

Findings may lead to the development of therapies to prevent damage to the retina, the light-sensitive tissue at the back of the eye. Boston, Mass. — Chemical eye burns caused by alkali agents not only injure the front of the eye — the cornea, where the contact takes place — but also cause...

Researchers identify new target for abnormal blood vessel growth in the eyes

Regulating transcription factor RUNX1 using small molecule drugs a promising novel therapy for diseases of the retina, including advanced diabetic eye disease. Boston, Mass.— A team led by Massachusetts Eye and Ear researchers has identified a novel therapeutic target for retinal neovascularization...

David A. Sullivan, PhD, to participate on panel to address TFOS DEWS II report

David A. Sullivan, PhD, was invited to participate on a panel to address the release of the conclusions and recommendations of the Tear Film and Ocular Surface Society’s (TFOS) Dry Eye Workshop II (DEWS II) Report. The panel also includes Janine Clayton, MD, and Susan Vitale, PhD, MHS. The panel...

Rising Star in Ophthalmology

Yoshihiro Yonekawa, MD, was included in The Ophthalmologist’s 2017 Power List. This list is created by the magazine’s leadership, who vote for ophthalmology’s top 50 rising stars. Dr. Yonekawa joined the Harvard Ophthalmology faculty in 2016, and specializes in adult and pediatric retina surgery...